Invitation to Cover: Major New Initiative to Defeat Pediatric Brain Tumors to be Announced at National Press Club

09 Sep 2016, 00:00 AM CDT

Model will fundamentally change the way pediatric cancer research and
drug discovery is funded and conducted

–(BUSINESS WIRE)–#braintumors–National Brain Tumor Society (NBTS):


WHAT		Launch of Project Impact: A Campaign to Defeat Pediatric Brain Tumors

WHEN		Monday, September 12, 2016
		Press Event: Noon – 1:00 PM (Media Registration: 11:45 AM)
		Reception: 1:30 – 3:00 PM

WHERE		National Press Club, 529 14^th Street NW, 13^th Floor, Washington, D.C. 20045

WHO		National Brain Tumor Society (NBTS) and several world renowned experts in the field of pediatric neuro-oncology

SPEAKERS		David Arons, JD: CEO, National Brain Tumor Society; President Pediatric Cancer Cure, LLC; Member, Blue Ribbon Panel, Cancer Moonshot Initiative; Chair, National Cancer Institute’s National Council of Research Advocates

		Roger J. Packer, MD: Senior VP of the Center for Neuroscience and Behavioral Medicine and Director of Brain Tumor Institute at Children’s National Medical Center; Scientific Director, Defeat Pediatric Brain Tumors Research Collaborative

		Suzanne J. Baker, PhD: Director of the Brain Tumor Research Division, Co-Leader of the Neurobiology & Brain Tumor Program, and Endowed Chair in Brain Tumor Research at St. Jude Children’s Research Hospital; Principle Investigator within the Defeat Pediatric Brain Tumors Research Collaborative

		Raphaël Rousseau, MD, PhD – Group Medical Director / Global Franchise Head, Pediatrics, Genentech, a member of the Roche Group

		Cord Schlobohm: Father of child lost to pediatric brain tumor and pediatric brain tumor research advocate; recently served as a patient advocate on the Peer-Reviewed Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Fund.

WHY		More than 4,600 children and adolescents (ages 0-19) will be diagnosed this year with a brain tumor, the most prevalent form of pediatric cancer. Brain tumors surpass leukemia as the deadliest form of cancer for kids under age 14. NBTS will announce details of a capital campaign that will provide sustainable support for research into pediatric brain tumors and promote a new model of collaboration and data-sharing within the pediatric neuro-oncology community to expedite discoveries and their translation toward new treatments.

About National Brain Tumor Society

National Brain Tumor Society (NBTS) is the largest nonprofit
organization in the US dedicated to the brain tumor community. We are
committed to finding better treatments and driving progress toward a
cure for brain tumors. We drive a multi-faceted and thoughtful approach
to influence and fund strategic research, as well as advocate for policy
changes, to achieve the greatest impact, results, and progress for brain
tumor patients. Money raised by the donations of our supporters directly
funds groundbreaking discoveries, programs, clinical trials and policy
initiatives. Learn more at www.braintumor.org

Contacts

National Brain Tumor Society (NBTS):
Media Contacts:
Tom
Halkin, 617-393-2849
thalkin@braintumor.org
or
Michael
Antonellis, 617-393-2841
mantonellis@braintumor.org